Home » Topics » BioWorld Science

BioWorld Science
RSS

Tracon files pivotal ENVASARC protocol with the FDA

July 17, 2020

Xenleta approved in Canada for community-acquired pneumonia

July 17, 2020

Phase III trial begins in UAE for Sinopharm's inactivated vaccine for COVID-19

July 17, 2020

Dynavax and Mount Sinai collaborate to develop a universal influenza vaccine

July 17, 2020

NIH grant supports development of Vivasc's CTP-amio for arrhythmia

July 17, 2020

Binding of MAO-A PET radiotracer [18F]FAZIN-3 observed in Parkinson's, Alzehimer's brain samples

July 17, 2020

Heron initiates phase II GUARDS-1 study of Cinvanti for the treatment of COVID-19

July 17, 2020

Bcl-2/Bcl-xl dual inhibitor AZD-0466 shows promise for treating ALL

July 17, 2020

Surface Oncology describes preclinical activity of anti-PVRIG antibody SRF-813

July 17, 2020

Recce and Path BioAnalytics collaborate in expanded SARS-CoV-2 program

July 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...